Results 11 to 20 of about 579,871 (293)

Primary extranodal diffuse large B‐cell lymphoma: Molecular features, treatment, and prognosis

open access: yesAging and Cancer, Volume 3, Issue 3-4, Page 133-146, September-December 2022., 2022
One‐third of DLBCL arises from extranodal organs and is challenging to manage. Molecular features are critical to elucidate the differences in clinical features, predict the disease prognosis, and improve effective targeted therapeutic strategies. Abstract Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin's lymphoma and ...
Si‐Yuan Chen   +3 more
wiley   +1 more source

Correction to: White-coat hypertension and incident end‑stage renal disease in patients with non‑dialysis chronic kidney disease: results from the C‑STRIDE Study

open access: yesJournal of Translational Medicine, 2020
An amendment to this paper has been published and can be accessed via the original article.
Qin Wang   +5 more
doaj   +1 more source

Serum uromodulin and progression of kidney disease in patients with chronic kidney disease

open access: yesJournal of Translational Medicine, 2018
Background Uromodulin is specifically synthesized and secreted by kidney tubular epithelial cells. Studies on the association of serum uromodulin and outcomes of chronic kidney disease (CKD) are lacking.
Li Lv   +9 more
doaj   +1 more source

White-coat hypertension and incident end-stage renal disease in patients with non-dialysis chronic kidney disease: results from the C-STRIDE Study

open access: yesJournal of Translational Medicine, 2020
Background Controversy remains whether white coat hypertension (WCH) is associated with renal prognosis in patients with chronic kidney disease (CKD). Methods In the present multicenter, prospective study, we analyzed data of participants with CKD stage ...
Qin Wang   +5 more
doaj   +1 more source

Potential Involvement of Complement Activation in Kidney Vascular Lesions of Arterionephrosclerosis

open access: yesFrontiers in Medicine, 2022
BackgroundComplement dysregulation has been implicated in the pathogenesis of malignant nephrosclerosis with typical pathological manifestation as thrombotic microangiopathy (TMA) in recent studies.
Xuejing Chen   +6 more
doaj   +1 more source

ADTKD-UMOD in a girl with a de novo mutation: A case report

open access: yesFrontiers in Medicine, 2022
Autosomal dominant tubulointerstitial kidney disease due to UMOD mutations (ADTKD-UMOD) is a rare condition associated with high variability in the age of end-stage kidney disease (ESKD). An autosomal dominant inheritance is the general rule, but de novo
Meng-shi Li   +36 more
doaj   +1 more source

Persistent hematuria in patients with antineutrophil cytoplasmic antibody-associated vasculitis during clinical remission: chronic glomerular lesion or low-grade active renal vasculitis?

open access: yesBMC Nephrology, 2017
Background Whether persistent hematuria in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) during clinical remission reflects active disease or chronic glomerular injury is uncertain.
Li Lv   +5 more
doaj   +1 more source

Unstably controlled systolic blood pressure trajectories are associated with markers for kidney damage in prediabetic population: results from the INDEED cohort study

open access: yesJournal of Translational Medicine, 2020
Background The association between blood pressure change and kidney damage in patients with abnormal blood glucose remains unclear. The current study aimed to identify systolic blood pressure (SBP) trajectories among the prediabetic population and to ...
Zi-Jun Sun   +9 more
doaj   +1 more source

Hemophagocytic lymphohistiocytosis followed by an episode of peritoneal dialysis associated peritonitis: a case report

open access: yesBMC Nephrology, 2019
Background Hemophagocytic lymphohistiocytosis (HLH) is characterized by excessive activation of the immune system due to infection, autoimmune diseases, or malignancy.
Bixia Gao   +3 more
doaj   +1 more source

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy

open access: yesFrontiers in Medicine, 2023
BackgroudRecent trials suggest sodium-glucose cotransporter 2 inhibitors (SGLT2i) significantly reduced proteinuria in patients with IgA nephropathy (IgAN).
Yaping Dong   +17 more
doaj   +1 more source

Home - About - Disclaimer - Privacy